Oral treatment with a novel small molecule alpha 4 integrin antagonist, AJM300, prevents the development of experimental colitis in mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral treatment with a novel small molecule alpha 4 integrin antagonist, AJM300, prevents the development of experimental colitis in mice
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 7, Issue 11, Pages e533-e542
Publisher
Oxford University Press (OUP)
Online
2013-04-24
DOI
10.1016/j.crohns.2013.03.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates
- (2012) Eric R. Fedyk et al. INFLAMMATORY BOWEL DISEASES
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
- (2011) EG Stefanich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Advances in the management of PML: Focus on natalizumab
- (2011) R. FOX CLEVELAND CLINIC JOURNAL OF MEDICINE
- Blocking Lymphocyte Localization to the Gastrointestinal Mucosa as a Therapeutic Strategy for Inflammatory Bowel Diseases
- (2011) Eduardo J. Villablanca et al. GASTROENTEROLOGY
- The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
- (2011) S. Vermeire et al. GUT
- Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study
- (2011) Asit Parikh et al. INFLAMMATORY BOWEL DISEASES
- Genetics and pathogenesis of inflammatory bowel disease
- (2011) Bernard Khor et al. NATURE
- Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
- (2011) Saskia Thomas et al. INFLAMMOPHARMACOLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- Review: Anti-adhesion molecule therapy for inflammatory bowel disease
- (2010) Subrata Ghosh et al. Therapeutic Advances in Gastroenterology
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- S1066 Oral Alpha-4 Integrin Inhibitor (AJM300) in Patients with Active Crohn's Disease — A Randomized, Double-Blind, Placebo-Controlled Trial
- (2009) Masakazu Takazoe et al. GASTROENTEROLOGY
- Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
- (2008) Brian G. Feagan et al. Clinical Gastroenterology and Hepatology
- Very late antigen-4 integrin antagonists
- (2008) Jefferson W Tilley EXPERT OPINION ON THERAPEUTIC PATENTS
- Dietary Histidine Ameliorates Murine Colitis by Inhibition of Proinflammatory Cytokine Production From Macrophages
- (2008) Ayatoshi Andou et al. GASTROENTEROLOGY
- Leukocyte adhesion molecules in animal models of inflammatory bowel disease
- (2008) Jesús Rivera-Nieves et al. INFLAMMATORY BOWEL DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More